MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202348053512 A) filed by Yuhan Corporation on August 09, 2023, for Anti-Tigit Antibodies And Uses Thereof.
Inventors include Lee, Kwang-Hoon; Lee, June Hyung; Lee, Rae; Jeong, Eunjeong; Park, Young Bong; Chang, Nakho; Lee, Eun-Jung; Kim, Ki Hong Number; Choi, Sunghyun; Choi, Byung Hyun; Park, Ju Young Filed On; Song, Moo Young; Lee, Jong-Seo; Kim, Kyu-Tae; and Ko, Bong-Kook.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to a novel antibody specifically binding to the tumorimmunosuppressant, TIGIT (T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif [ITIM] domain) or an antigen-binding fragment thereof, a nucleic acid encoding the antibody or the antigen-binding fragment thereof, a vector and a host cell including the nucleic acid, a method for producing the antibody or the antigen-binding fragment thereof, a pharmaceutical composition containing the antibody or the antigenbinding fragment thereof as an active ingredient, and uses of the pharmaceutical composition. The antibody specifically binding to TIGIT or the antigen-binding fragment thereof and the pharmaceutical composition containing the same as an active ingredient are preferably used for the treatment of cancer or tumors.
Disclaimer: Curated by HT Syndication.
